News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • South Africa: Shortage of drug puts thousands of Aids patients at risk

    Health authorities have confirmed the shortage of Darunavir, a third-line drug. Third-line drugs are used when patients have few drug options left to treat their condition.

    15 March 2019 | Independent Online
  • India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

    Based out of the Humsafar Trust’s office jn Mumbai, the centre will give free counselling and provide Anti-Retroviral Therapy (ART) to the LGBTQ community. TAshok Row Kavi, founder chairperson of the Trust, said: “Until now we would get testing done for the community members at our centre. If tested positive for the disease, they would be asked to go to Sion Hospital, but there was a huge dropout (rate) there. Because of how the community is perceived outside, a lot of these people wouldn’t seek treatment."

    12 March 2019 | Hindustan Times
  • Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

    Dozens of patient advocacy groups, like the Bonnie J. Addario Lung Cancer Foundation and the National Coalition for Cancer Survivorship, recently appeared in national advertisements objecting to a Trump administration proposal that could limit drugs covered by Medicare providers. But a Kaiser Health News analysis found that about half of the groups representing patients have received funding from the pharmaceutical industry.

    05 March 2019 | Kaiser Health News
  • Should the NIH Break HIV Prevention Drug Truvada's Patent?

    Should a biotech giant holding a valuable patent be forced to give it up if doing so would serve the public good? That’s the mounting debate over Gilead Sciences’ hold on an HIV prevention treatment, which some say is too expensive and should be available to all.

    05 March 2019 | Fortune
  • San Francisco Is Beating H.I.V. Why Can’t Houston?

    We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

    04 March 2019 | The New York Times
  • Examining the Truvada #BreakThePatent Debate: Gilead Responds

    A review of how patents affect access to Truvada, and Gilead's response on calls for march-in rights to be granted on patents in order to facilitate access.

    04 March 2019 |
  • A new way to pay for innovative drugs, provide universal access and not break the bank

    Louisiana, which has a severe hepatitis C problem, is on the cusp of proving to other states that drug companies can make the money they need, while every Medicaid recipient who needs a cure gets one. The state is now on a path to secure immediate treatment for all infected prisoners and people on Medicaid by buying a license from a drug company. It is a concept that can be applied to other ground breaking remedies.

    28 February 2019 | The Conversation
  • Analysis: How a cutting edge medicine made it to South Africa’s new ARV tender

    South Africa’s recently awarded antiretroviral (ARV) tender, worth around R14-billion over three years, heralds the introduction of a much-anticipated new medicine called dolutegravir into the public healthcare system from July 2019. For a cutting-edge HIV drug to reach the public sector so quickly, and at such a low price, is unprecedented.

    27 February 2019 | Spotlight
  • The Good Law Project threatens Judicial Review of Serious Shortage Protocols

    The Good Law Project has today threatened to issue judicial review proceedings on Tuesday 26 February unless Government cancels powers to allow pharmacists to alter prescriptions for people with serious medical conditions in the event of medicines shortages. The powers – called “Serious Shortage Protocols” (SSPs) – give pharmacists the right to supply a different quantity or pharmaceutical quality of medicine in the event of the country experiencing a serious shortage of prescription-only medicines after 29 March 2019. These new powers took force on 9 February, and have been criticised for being rushed out without proper consultation with patient and clinical groups.

    24 February 2019 | Good Law Project
  • 'I came to Peru to survive': Venezuelans migrating for HIV drugs

    Darwin Zerpa is among those who have fled to Peru to get the antiretrovirals he needs. Now he counsels others with the virus.

    24 February 2019 | The Guardian
More news
Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.